Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Over 286,000 Women in Arizona Affected by Domestic Gag Rule


“Even before the domestic gag rule went into effect, more than 453,000 low-income women in Arizona lived in contraceptive deserts, counties in which there is not reasonable access to the full range of contraceptive methods,” said Gillian Sealy, CEO, Power to Decide.

According to data released by Power to Decide, an estimated 286,020 Arizona women of reproductive age (13-44) in need of publicly funded contraception live in a county impacted by the implementation of the Title X Family Planning Program “domestic gag rule.” According to the same data, two out of Arizona’s 15 counties have lost some Title X resources.

The domestic gag rule requires health providers receiving Title X funds to withhold some information from patients about abortion services and care. In addition, health centers are required to cease providing abortion care with non-Title X funds at sites that offer Title X supported services, such as contraceptive care, breast and cervical cancer screening and STI testing. The new rule requires that abortion services, no matter how they are funded, must be performed at a separate physical site, which is impossible for many health centers. In the face of these challenges, family planning providers are doing their best to provide high-quality services to their patients and fill gaps left in the wake of the disruption caused by the rule

“The implementation of the domestic gag rule could impact more than 286,000 women in need in Arizona,” said Gillian Sealy, CEO, Power to Decide. “This federal rule exacerbates an already challenging contraceptive access landscape for women struggling to make ends meet. Even before the domestic gag rule went into effect, more than 453,000 low-income women in Arizona lived in contraceptive deserts, counties in which there is not reasonable access to the full range of contraceptive methods. As a result, these women face financial barriers related to transportation, child care and taking unpaid time from work; costs they incur just to get the contraception they need.”

Data from Power to Decide show that 453,430 women living at or below 250% of the poverty level in Arizona live in contraceptive deserts, counties in which there is not reasonable access to a health center offering the full range of contraceptive methods. Nationally, more than 19 million U.S. women of low income live in contraceptive deserts.

In this challenging landscape, states like Arizona can take steps to partially alleviate the impact of damaging federal policies and to proactively expand access to contraception in various ways. Arizona has already expanded Medicaid to low-income adults, which helps decrease the percentage of uninsured women, and by extension, give them contraceptive coverage. In addition, allowing pharmacists to prescribe contraception and requiring insurance to cover an extended supply of prescription contraceptives can make it easier to access some contraceptive methods. Arizona can also guard against additional barriers to access by enacting policies that protect insurance coverage of the full range of contraceptive methods. More information about these policies can be found here.

Power to Decide is a private, non-partisan, non-profit organization that works to ensure all people—no matter who they are, where they live or what their economic status might be—have the power to decide if, when and under what circumstances to get pregnant and have a child. Please visit us at http://www.PowerToDecide.org or follow us on Facebook and Twitter.

Share article on social media or email:



HiDO Data Analytics Appoints Dr. Kathy Donneson


“The unique HiDO telepharmacy design pushes the envelope in accurate and reliable medication adherence, reduces drug waste, and improves patient outcomes thereby lowering pharmacy costs,” said Dr. Donneson.

Donneson Is a Veteran Health Plan Leader and Has Held Senior Positions at CALPERS and the United States Air Force

NEWS PROVIDED BY

HiDO Technologies

August 31, 2020, 07:03 PT

HiDO advanced data analytics, a company focused on accelerating drug development, eliminating medication errors and ending medication waste expands Advisory Team. Kathleen Donneson, DPA brings more than 30 years of experience in health plans and research leadership and strategy to HiDO. She has held senior leadership positions at one of the largest health plans purchasers, California Public Employees Retirement System (CalPERS). Dr. Donneson also served as a Colonel in the United States Air Force Reserve for over 26 years.

“We are thrilled to have Kathy join our Advisors as many health plans struggle with managing speciality medication costs and adherence,” said Brandon Woolsey, CTO of HiDO. “She has been a trusted advisor to the company for the last 12 months and brings a wealth of health plan experience having managed a $9.5 Billion health plan benefit programs. We are grateful to have her guidance as we continue to expand our data analytics research and strategic partnerships.”

“The unique HiDO telepharmacy design pushes the envelope in accurate and reliable medication adherence, reduces drug waste, and improves patient outcomes thereby lowering pharmacy costs” said Dr. Donneson. “Especially critical at this time, efforts like this give purchasers, health plans, and pharmacy benefit managers greater clarity on medication compliance and effectiveness.”

About HiDO Data Analytics

HiDO advanced data analytics, a company focused on accelerating drug development, eliminating medication errors and ending medication waste. The HiDO team includes experts in drug discovery and development, clinical research, biomedical informatics and artificial intelligence. For more information, please visit hidohealth.com/.

Related Links

hidohealth.com/

Share article on social media or email:

Martin Technical Welcomes Troy Gaytan as Key Account Manager


Martin Technical, Inc. is pleased to announce its hiring of Troy Gaytan as Key Account Manager. Troy has been in sales and customer service for over 30 years, and specifically in safety for 5 years, selling PPE and safety programs for accounts such as Toyota Motor Manufacturing and Dow Chemical.

With many opportunities in the marketplace for a good salesman, Troy reflects on his decision to join Martin Technical, “In PPE sales, I had the chance to partner with Martin Technical for some facility services my customer needed. Partnering with Martin Technical allowed me to meet and work with some of the people at Martin and I was impressed. When my old mentor, Gil, ended up at Martin Technical, I knew I needed to be part of this team.”

As a Key Account Manager, Troy will manage the distribution network, drive sales for training and services, and manage the quotes and jobs in the eastern region for all verticals.

Gayton distinguishes his decision in working in the safety industry and specifically Martin Technical. He believes in the company culture behind Martin Technical, but on a larger scale, takes pride in working in the safety industry, stating, “My work helps others stay safe, perhaps even alive. That means something.”

To contact Troy Gaytan, please email TroyG@MarTechnical.com.

About Martin Technical / Safety Hive

Martin Technical is a privately held safety solutions company whose mission is to improve workforce safety by providing reliable and trusted solutions by employees who care about the greater good. We are experts in providing practical safety and efficiency services that make plants and facilities better, safer and more efficient. Martin Technical safety services include engineering, inspection, implementation, consulting and training services. Safety Hive, a wholly owned subsidiary of Martin Technical, is a Safety Technology Solution and Software Provider that digitizes and automates safety to help predict and prevent workplace safety incidents through technology and data.

To learn more, please visit http://www.MarTechnical.com, http://www.SafetyHive.com, call 866-234-6890, or email Info@MarTechnical.com.

Share article on social media or email:

ATSNJ Survey Results for NJSIAA COVID-19 Summer Recess Period Released


ATSNJ logo

“Integral to this recess period are the licensed athletic trainers which are being depended on by school administrators, athletic directors and coaches to help ensure that student-athlete health is monitored and actions are taken to address potential virus-related situations.”

The Athletic Trainers’ Society of New Jersey (ATSNJ) announced survey results of 152 licensed athletic trainers employed at New Jersey Interscholastic Athletic Association (NJSIAA) member schools participating in the athletic summer recess period during the period of July 13 – August 28. The survey, conducted by the ATSNJ, a professional organization in New Jersey composed of athletic trainers and other health care professionals, highlights the value of athletic trainers in New Jersey secondary schools and evaluates COVID-19 protocols in athletics as our student-athletes resume activities across the state.

“In response to the uncertainty and disruption facing secondary school athletics in the state of New Jersey, the ATSNJ thought it was prudent to collect data from athletic trainers across the state to see how schools have fared so far during the return to sports in the current COVID-19 environment,” said Kevin Briles, President of the ATSNJ.

Survey highlights include:

  • 172 athletic trainers responded in total to the survey.
  • Of the total group that participated in the survey, 152 athletic trainers responded whose schools conducted summer recess athletic workouts.
  • Survey expressed coverage of over 30,000 student-athletes.
  • 33% of schools identified a potential COVID-19 case through their screening process.
  • 18% of schools identified a positive Covid-19 case through their screenings.
  • 23.38% of schools had a reason to shut down a workout pod of athletes due to COVID-19 exposure.
  • 12.34% of schools shut down an individual sports team due to Covid-19 exposure.
  • 54 total athletes were identified as Covid-19 + (.0018 positive rate) 54/30,000.
  • Athletic Trainers at 68.48% of schools oversaw the COVID-19 protocols.
  • 97.06% of schools relied on NJSIAA protocol recommendations.
  • 79% of Athletic trainers surveyed feel the protocols have been successful.

Statistical analysis indicated there was no significant difference in response patterns across NJSIAA groupings (Group 1-5) or regions (North, Central, or Southern) in the state (p>.05).

“We are encouraged that due to the preparation of school districts across the state, along with guidance from the NJSIAA, high school athletics in New Jersey has quickly adapted its processes to best address the needs of student-athletes during this unprecedented time,” said Briles. “Integral to this recess period are the licensed athletic trainers which are being depended on by school administrators, athletic directors and coaches to help ensure that student-athlete health is monitored and actions are taken to address potential virus-related situations.”

In the COVID-19 environment, the ATSNJ believes that future athletic participation recommendations should be based on the best available scientific evidence in order to ensure the health, safety and well-being of student-athletes in the state of New Jersey. The ATSNJ continues to advance best practices for ensuring that athletes and the physically active population participate in sports in a safe environment and receive the best health care possible. As cited in this survey’s results, licensed athletic trainers play a significant role in the implementation and success of COVID-19 protocols in the high school athletics environment. ATSNJ members across the state will continue to be at the front-line of this pandemic, offering their expertise on a daily basis so that as the school year begins, high school sports can function in a competitive, enjoyable and safe way for the state’s student-athletes and their families.

For more detailed survey results, please visit: https://www.atsnj.org/covid19

For more information about the ATSNJ, please visit our website at http://www.atsnj.org or social media pages on Facebook @NJSportSafety, Twitter @ATSNJ, and Instagram @ATSNJ.

Share article on social media or email:

NES Health reveals secrets to gaining more clients


NES Health provides practitioners focused on wellness with a unique way to support the health of those looking for natural alternatives.

The Bionergetix WellNES System allows practitioners to view blockages in a person’s biofield. These blockages can reveal the true root cause of less-than-optimal health.

“Though the science surrounding bioenergetics is complex, NES Health has the easiest, most effective, and educative platform in bioenergetic health. But we were missing a key component Dean Akers can offer our practitioners — business education,” says founder, Harry Massey.

Dean Akers has a no-nonsense approach to business that eliminates destructive self-talk that hinders so many companies. He has a proven track record of growing companies for over 40 years both as a consultant and working directly with them as a CEO.

Each Thursday, Dean heads a new topic to help practitioners attract more clients and maximize their efforts.

In a time where remote practices are necessary to having a successful health business, it is imperative that businesses hone their marketing skills to reach a wide audience while building relationships with clients.

“The end goal,” says Tom Klausing, Chief Marketing Office, “is to help our practitioners be successful and give as many people as possible a genuine way to have energy for life.”

Share article on social media or email:

NeoTract Designates Dr. Christopher Cantrill as UroLift® Center of Excellence


News Image

“Dr. Christopher Cantrill has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Christopher Cantrill, M.D., Urology San Antonio in San Antonio, TX, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Cantrill has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Christopher Cantrill has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

HairMax Celebrates 20 Years of Innovation in Laser Phototherapy Devices for Hair Regrowth


News Image

“This has been the most interesting and rewarding 20 years of my life”, Mr. Michaels said.” We have adapted to the needs of the market, grown our product line to meet the demand, and never stopped innovating.”

HairMax has reached a historic milestone as the company celebrates 20 years of delivering breakthrough laser hair growth devices and thinning hair care formulas. Through its innovative solutions HairMax has helped hair loss sufferers, regrow their hair, regain their confidence and enrich their lives. These achievements have led the HairMax brand to become the worldwide leader in laser hair growth technology.

The company, Lexington International, LLC., originated in 2000 in Sydney, Australia, created a new category in laser hair growth. Led by the original Founder and Managing Director, Mr. David Michaels, it has continued its privately-held ownership throughout its history, allowing full control to innovate the product line, maintain a robust growth strategy, make business decisions quickly, and ensure a consistent focus on customers. A sharp focus on innovation has enabled the company to meet and exceed both industry and customers’ evolving needs, expectations, and market demands.

For an in-depth interview with Mr. David Michaels and celebratory video footage.

Visit: https://hairmax.com/blogs/news/hairmax-celebrates-20th-anniversary

Today, HairMax is available direct to consumers, through retail partners such as Costco and Bed Bath & Beyond, International Distributors, Hair Salons and Physician Offices. HairMax is also offered via TV shopping channels worldwide and has been nominated for 8 QVC customer choice awards.

David Michaels, reflects on the company’s 20th anniversary, “This has been the most interesting and rewarding 20 years of my life. We have adapted to the needs of the market, grown our product line to meet the demand, and never stopped innovating.” Mr. Michaels further stated: “We started out by identifying an unmet need in the marketplace, listening to our customers, and delivering the highest quality product at price points for every budget. Our founding belief is ‘We Care’ and this remains our guiding philosophy today. A big thank you to the millions of valued customers and partners around the world.”

Since its inception in 2000, HairMax has conducted 7 clinical studies, with results published in 6 peer reviewed articles, has received 8 FDA Clearances, and has been granted 14 medical device licenses. There are now 1.8+ million devices worldwide.

HairMax: Evolution and Milestones:

  • 2000 – HairMax is founded in Sydney, Australia and relocates to Boca Raton, Florida.
  • 2007 – HairMax LaserComb receives FDA 510(k) Clearance for marketing as an OTC Class II medical device for the treatment of Androgenetic Alopecia (AGA) and promotion of hair growth in males.
  • 2009 – First cordless LaserComb model receives FDA Clearance.
  • 2009/2010 – Three additional clinical studies completed on males and females with AGA.
  • 2011 – Clinical research studies program on HairMax for the treatment of AGA completed with 460 male and females subjects.


FDA Clearance for marketing granted for the HairMax Advanced 7 LaserComb and Professional 12 LaserComb for AGA in females.

  • 2014 – Landmark clinical study with 4 LaserComb models and 225 male and female subjects published in the peer review journal, The American Journal of Clinical Practice April 2014, Volume 15, Issue 2, pp115-127,
  • 2015 – Introduction of the FIRST LaserBand device, with 82 medical grade lasers, fastest treatment time on the market and unique band design.
  • 2016 – Introduction of the HairMax LaserBand 41 ComfortFlex, with unique flexible band design
  • 2018 – The first HairMax Laser Cap is introduced, incorporating 272 medical grade lasers, and engineered to surpass all other laser caps on the market in comfort, flexibility, electronic quality and usability.


HairMax launches Density Bio-Active Hair Therapy with proprietary NRG8-pLEX™ and Liposome Delivery System.

  • 2020 – New LaserBand 82 Flex and 2 new Laser Cap models soon to be introduced!

About HairMax

Based in Boca Raton, Florida, Lexington Int’l is the pioneer in laser hair growth technology for home use. HairMax is the FIRST laser light device on the market to receive FDA clearance as a medical device to treat hair loss and stimulate hair growth. HairMax Laser Devices have been the subject of 7 clinical studies proving both efficacy and safety with an over 90% success rate. HairMax Laser Devices hold 8 FDA clearances and 14 medical device licenses world-wide.

Visit http://www.hairmax.com for further information.

Media Contact:

Francesca Dubsky, Director of Marketing

fd@hairmax.com

Share article on social media or email:

ASSP’s SafetyFOCUS SMS Virtual Conference to Include ProAct Safety Sessions on Leading Indicators and Safety Excellence


Shawn Galloway (L) & Terry Mathis (R)

distinguish between basic and excellent safety or discuss the evolution of safety measurements

ProAct Safety, a recognized pioneer of safety excellence strategies, announced its Principals, Terry L. Mathis and Shawn M. Galloway, will be leading sessions at the upcoming American Society of Safety Professionals (ASSP) virtual Safety FOCUS: Safety Management Systems, on September 16-17.

Mathis’ session, “What Differentiates Safety Excellence from Basic Safety,” details why doing basic safety better will not achieve safety excellence. Attendees will learn how the best in safety have advanced and matured their approaches and metrics to address the gap between current performance and excellent performance. Develop knowledge and take away tools to help you move from managing and measuring results to managing and measuring the true drivers of results. (Sept 16 at 1:45pm CT)

Galloway’s session, “Pushing Past Leading Indicators – Measuring Progress and Value,” details how safety indicators have evolved. Attendees will learn how the best in safety have advanced and matured their measurements and metrics from lagging to leading to value-based to balanced scorecards. Develop knowledge and take away tools to help you move from measuring results to assessing the true drivers of results. (Sept 17 at 12:30pm CT)

For more information about ProAct Safety events, visit http://proactsafety.com/events.

ABOUT TERRY L. MATHIS

Mathis, ProAct Safety’s founder and CEO, is known for dynamic presentations, work and writing in the fields of behavioral and cultural safety, leadership, and operational performance. He is a regular speaker at ASSE and NSC, as well as company and industry conferences. He has been a frequent contributor to industry magazines for more than 15 years and is coauthor of five books, including bestsellers STEPS to Safety Culture Excellence (WILEY, 2013) and Forecasting Tomorrow: The Future of Safety Excellence (SCE Press, 2015). Terry has been listed four consecutive times as one of ‘The 50 People Who Most Influenced EHS’ by EHS Today. Learn more about him at http://www.TerryLMathis.com.

ABOUT SHAWN M. GALLOWAY

Shawn M. Galloway is the President of the global consultancy, ProAct Safety. He is a consultant, professional speaker and author of several bestselling books on safety strategy, culture, leadership and Behavior-Based Safety. He is a monthly columnist for several magazines and one of the most prolific contributors in the industry, having authored over 600 podcasts, 200 articles and 100 videos. Shawn’s consulting clients include most of the best safety-performing organizations and has worked across every major industry. He has received awards and recognition for his significant contributions from the American Society of Safety Professionals Council on Practices & Standards, National Safety Council’s Top 40 Rising Stars, EHS Today Magazine’s 50 People Who Most Influenced EHS, ISHN Magazine’s POWER 101 – Leaders of the EHS World and their newest list: 50 Leaders for Today and Tomorrow and Pro-Sapien’s list of The Top 11 Health and Safety Influencers of 2019. Read more about him and his work at http://www.ShawnGalloway.com.

ABOUT PROACT SAFETY

ProAct Safety is a global safety excellence consultancy. The company has completed more than 2,000 successful safety strategy, leadership, culture and behavior-based safety projects in nearly every major industry worldwide. Learn more at http://www.ProActSafety.com.

Share article on social media or email:

Evaluate Rapid Testing and Gain Strategies to Move Forward from St. Edward’s University, Other Academic Institutions, and Businesses


News Image

Businesses only get one opportunity to reopen. This webinar will describe how to prepare your business and its stakeholders to bring your workforce back and operate safely during the COVID pandemic

Validation Institute and World Congress are hosting a one-hour webinar on Thursday, September 3, at 2PM EDT titled, “Roadmap to Safely Reopening: Evaluate Rapid Testing and Gain Strategies to Move Forward from St. Edward’s University, Other Academic Institutions, and Businesses.”

This webinar is designed for leaders in health care, HR, retail, education, hospitality, manufacturing, pro-services, faith based institutions, and youth programs. The webinar will cover safety precautions, protocols, and guidelines related to safely reopening during the COVID-19 pandemic. Attendees will gain strategies and hear lessons learned from St. Edward’s University, whose COVID-19 response and reopening model was revered by their local public health department.

In addition, Validation Institute is hosting a training program, OpenSafe, where attendees will receive a comprehensive course from characteristics of the virus to creating a customized plan specific for their organization’s employees and safety protocols.

Registration for the webinar is complimentary. Register now

Registration for the FULLY REFUNDABLE 20+ module OpenSafe training course is $495 and available here.

Webinar topics include:

  • How to efficiently reopen businesses including schools, restaurants, hotels, and others while ensuring the safety of employees, staff, students, and the broader community
  • Lessons learned directly from St. Edward’s University staff including roadblocks and challenges
  • Resources available to business as they reopen including safety precautions, protocols, and guidelines

Webinar participants will hear from leading experts from St. Edward’s University and Accountable Health who developed and executed a strategic plan to reopen the St. Edward’s University campus. Panelists include Liz Johnson, Director of Government & Community Relations and Justin Sloan, Vice President for Institutional Effectiveness and Planning and Chief Data Officer at St. Edward’s University. Also participating will be moderator, Fred Goldstein, President and Founder of Accountable Health, LLC along with his colleagues, Nick Van Terheyden, MD, Managing Director and Strategist, Incremental Healthcare; Medical Advisor and Luis Saldana, MD, Medical Advisor at Accountable Health, LLC.

As states have started to reopen, many reported increases in cases, causing many businesses to close their doors for good. Businesses only get one opportunity to reopen. This webinar will describe how to prepare your business and its stakeholders to bring your workforce back and operate safely during the COVID pandemic. In addition, speakers will talk about their experience, resources available, and best practices they have established to help you reopen and operate in the New Normal.

About Validation Institute

Validation Institute is an independent, third-party resource for health care purchasing professionals, health care vendors, and benefits advisors. The organization focuses on price and outcomes transparency and accuracy in key areas of health care as a way to reduce health care costs while improving outcomes and member satisfaction.

For additional information go to http://www.validationinstitute.com or e-mail viprocess@validationinstitute.com.

For Sponsorship opportunities, contact Bridget Kelly at 781-939-2630 or e-mail her at bridget.kelly@worldcongress.com.

For press interviews or other inquires related to this webinar, e-mail Vidar Jorgensen at vidar.jorgensen@validationinstitute.com

XXX

Share article on social media or email:

U.S. Dermatology Partners is excited to welcome Dermatologist Arathi Rana, MD to its Sherman and Paris offices


Dr. Arathi Rana, Dermatologist

Arathi Rana, MD, Dermatologist

U.S. Dermatology Partners is excited to welcome Dermatologist Dr. Arathi Rana to its Sherman and Paris offices

Arathi R. Rana, MD was born and raised in Allen, Texas. She attended Austin College where she earned her bachelor’s degree and was inducted into the Psi Chi International Honor Society, graduating Cum Laude. She then went on to earn her medical degree from Texas A&M College of Medicine. During her time in medical school, she was inducted into the prestigious Alpha Omega Alpha Honor Society as a junior member and graduated in the top 5% of her class. She also received the Glasgow-Rubin Certificate of Achievement and Glasgow-Rubin Commendation awards for her academic accomplishments.

After medical school, Dr. Rana completed her internship and dermatology residency at The University of Texas Medical Branch (UTMB) in Galveston, Texas. She received an award for two consecutive years during her residency from the American Society of Dermatologic Surgery (ASDS) to train under national leaders within the field of Cosmetic Dermatology. She also authored numerous publications and presented her work at both local and national conferences. In her final year of residency, she was selected as the Academic Chief Resident and awarded the UTMB Dermatology Resident Research Award for her study in aesthetic medicine. Dr. Rana’s professional interests include detection and management of skin cancers; cosmetic treatments including neuromodulators (e.g., Botox), dermal fillers, sclerotherapy; the treatment of acne, warts, hyperpigmentation; and cyst/lipoma removal.

Dr. Rana and her husband, a facial plastic surgeon, reside in North Texas with their fun-loving German Shepherd. Her personal interests include spending time with family and friends, going to the dog park, trying new restaurants, spin class, interior design, and traveling.

Dr. Rana treats patients at U.S. Dermatology Partners in Sherman and Paris, Texas, and is accepting new patients. To schedule an appointment call 903-892-2126 for Sherman and 903-576-7290.

About U.S. Dermatology Partners

As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners’ patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network, but also benefit from the practice’s strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.

Share article on social media or email: